Sparrow K, Shrestha R, Wood J, Clinch K, Hurst B, Wang H
ACS Med Chem Lett. 2023; 14(4):506-513.
PMID: 37077387
PMC: 10108398.
DOI: 10.1021/acsmedchemlett.3c00048.
Thangarasu A, Yadhukrishnan V, Krishnakumar K, Varma S, Lankalapalli R
ACS Org Inorg Au. 2023; 2(1):3-7.
PMID: 36855403
PMC: 9954286.
DOI: 10.1021/acsorginorgau.1c00015.
Gebre S, Cameron S, Li L, Babu Y, Schramm V
J Biol Chem. 2017; 292(38):15907-15915.
PMID: 28794158
PMC: 5612120.
DOI: 10.1074/jbc.M117.801779.
Shelton J, Lu X, Hollenbaugh J, Cho J, Amblard F, Schinazi R
Chem Rev. 2016; 116(23):14379-14455.
PMID: 27960273
PMC: 7717319.
DOI: 10.1021/acs.chemrev.6b00209.
Temburnikar K, Ross C, Wilson G, Balzarini J, Cawrse B, Seley-Radtke K
Bioorg Med Chem. 2015; 23(15):4354-4363.
PMID: 26122770
PMC: 5661880.
DOI: 10.1016/j.bmc.2015.06.025.
Direct synthesis of imino-C-nucleoside analogues and other biologically active iminosugars.
Bergeron-Brlek M, Meanwell M, Britton R
Nat Commun. 2015; 6:6903.
PMID: 25903019
PMC: 4558570.
DOI: 10.1038/ncomms7903.
Synthesis of the new ring system bispyrido[4',3':4,5]pyrrolo [1,2-a:1',2'-d]pyrazine and its deaza analogue.
Parrino B, Spano V, Carbone A, Barraja P, Diana P, Cirrincione G
Molecules. 2014; 19(9):13342-57.
PMID: 25178059
PMC: 6270686.
DOI: 10.3390/molecules190913342.
Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines.
Temburnikar K, Zimmermann S, Kim N, Ross C, Gelbmann C, Salomon C
Bioorg Med Chem. 2014; 22(7):2113-22.
PMID: 24631358
PMC: 4565497.
DOI: 10.1016/j.bmc.2014.02.033.
Synthesis of 2'-deoxy-9-deaza nucleosides using Heck methodology.
Temburnikar K, Brace K, Seley-Radtke K
J Org Chem. 2013; 78(14):7305-11.
PMID: 23806030
PMC: 5638437.
DOI: 10.1021/jo400913k.
Transition state analogue inhibitors of human methylthioadenosine phosphorylase and bacterial methylthioadenosine/S-adenosylhomocysteine nucleosidase incorporating acyclic ribooxacarbenium ion mimics.
Clinch K, Evans G, Frohlich R, Gulab S, Gutierrez J, Mason J
Bioorg Med Chem. 2012; 20(17):5181-7.
PMID: 22854195
PMC: 3438226.
DOI: 10.1016/j.bmc.2012.07.006.
Enzymatic transition states, transition-state analogs, dynamics, thermodynamics, and lifetimes.
Schramm V
Annu Rev Biochem. 2011; 80:703-32.
PMID: 21675920
PMC: 5502542.
DOI: 10.1146/annurev-biochem-061809-100742.
Four generations of transition-state analogues for human purine nucleoside phosphorylase.
Ho M, Shi W, Rinaldo-Matthis A, Tyler P, Evans G, Clinch K
Proc Natl Acad Sci U S A. 2010; 107(11):4805-12.
PMID: 20212140
PMC: 2841916.
DOI: 10.1073/pnas.0913439107.
Plasmodium falciparum purine nucleoside phosphorylase is critical for viability of malaria parasites.
Madrid D, Ting L, Waller K, Schramm V, Kim K
J Biol Chem. 2008; 283(51):35899-907.
PMID: 18957439
PMC: 2602904.
DOI: 10.1074/jbc.M807218200.
Immucillins in custom catalytic-site cavities.
Murkin A, Clinch K, Mason J, Tyler P, Schramm V
Bioorg Med Chem Lett. 2008; 18(22):5900-3.
PMID: 18778937
PMC: 2614083.
DOI: 10.1016/j.bmcl.2008.08.047.
A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine).
Gandhi V, Kilpatrick J, Plunkett W, Ayres M, Harman L, Du M
Blood. 2005; 106(13):4253-60.
PMID: 16131572
PMC: 1895256.
DOI: 10.1182/blood-2005-03-1309.